Physician profile
Stuart J Newman
NPI 1255338653
$3,335.08
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $965 · 2020: $420 · 2021: $641 · 2022: $829 · 2023: $480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $480.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $544.14 | 2019-2023 | Cequa |
| Coopervision INC. | $514.09 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $442.09 | 2019-2023 | |
| Allergan, INC. | $224.28 | 2019-2022 | |
| Carl Zeiss Meditec, INC. | $208.03 | 2019-2020 | |
| Shire North American Group INC | $155.31 | 2019 | |
| Kala Pharmaceuticals, INC. | $151.85 | 2020-2022 | |
| Glaukos Corporation | $124.76 | 2019 | |
| Mallinckrodt Hospital Products INC. | $115.73 | 2021 | |
| Quidel Corporation | $95.41 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $83.36 | 2019-2021 | |
| Oyster Point Pharma, INC. | $80.40 | 2022-2023 | Tyrvaya |
| Abbvie INC. | $75.39 | 2022-2023 | |
| Biotissue Holdings INC. | $74.63 | 2019-2022 | |
| Thea Pharma INC. | $72.80 | 2022-2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Akorn, INC. | $71.02 | 2019-2020 | |
| Eyevance Pharmaceuticals LLC | $58.31 | 2019-2020 | |
| Aerie Pharmaceuticals, INC. | $53.88 | 2019-2021 | |
| Akorn Operating Company LLC | $51.61 | 2021 | |
| Alcon Vision LLC | $41.19 | 2022-2023 | Rocklatan |
| Johnson & Johnson Surgical Vision, INC. | $34.85 | 2019-2020 | |
| Bausch & Lomb Americas INC. | $24.46 | 2023 | Vyzulta |
| Sight Sciences, INC. | $20.64 | 2022 | |
| Dompe US, INC. | $16.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Newman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.